Japan

How Japan can unlock offshore wind potential

It must optimise evaluation criteria, focusing on realistic price limits.

Manulife Japan recognised at Asian Innovation Excellence Awards 2025 for AI Assistant

The AI Assistant chatbot boosts efficiency of agent sales representatives and enhances customer service.

Manulife Japan lauded at Asian Innovation Excellence Awards 2025 for customer-centred design

Human-centred design system improves digital platforms and enhances customer experience.

Manulife Japan wins at Asian Innovation Excellence Awards 2025 for breakthrough brand campaign

The “Living Longer, Living Better” campaign challenges Japan’s perceptions of longevity by inspiring optimism and proactive planning.

Japan’s hip reconstruction market to be valued at $570m by 2036.

The country accounted for around 30% of the APAC market in 2024.

Here’s what’s driving Japan’s retail leasing demand

Korean and Chinese brands are expanding rapidly in fashion, F&B, and cosmetics.

How Japan's non-life insurers record $12.4b net income in fiscal 2024

As of 30 April, 57 general insurance companies were operating in Japan.

How Japan can refuel its renewable energy pledge

The country faces challenges in terms of its system and regulations.

Japan’s slowing hotel pipeline opens door for foreign hotel brands

Traditional inns continue to dominate the accommodation sector.

Japan faces RE supply chain conundrum

It’s a choice between creating jobs later or now at the expense of higher energy prices.

Here’s what’s next for Japan’s mycobacterium tuberculosis tests market

The country accounted for about 4% of the Asia-Pacific market in 2024.

How much will Japan's insurance market grow in eight years?

Demographic shifts are driving structural changes in product demand.

Japan’s nuclear energy generation up 11.2% in FY 2024

Thanks to several units resuming operations last year.

Japan coal plants face losses with ammonia co-firing

Costs are seen to surge for plants using half blue ammonia

Japan’s 10-year fund to boost pharmaceutical landscape

The country’s ageing population is driving demand for innovative treatments.